Haverford Financial Services Inc. cut its holdings in McKesson Corporation (NYSE:MCK – Free Report) by 7.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,686 shares of the company’s stock after selling 1,009 shares during the quarter. McKesson accounts for 2.8% of Haverford Financial Services Inc.’s investment portfolio, making the stock its 16th largest holding. Haverford Financial Services Inc.’s holdings in McKesson were worth $9,296,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of MCK. Solstein Capital LLC lifted its position in shares of McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after acquiring an additional 24 shares during the period. Bank of Jackson Hole Trust grew its holdings in McKesson by 64.3% in the first quarter. Bank of Jackson Hole Trust now owns 46 shares of the company’s stock worth $29,000 after purchasing an additional 18 shares during the period. GFG Capital LLC bought a new stake in McKesson in the second quarter valued at $30,000. Saudi Central Bank acquired a new position in shares of McKesson during the first quarter valued at about $34,000. Finally, Flaharty Asset Management LLC acquired a new position in shares of McKesson during the first quarter valued at about $39,000. 85.07% of the stock is currently owned by institutional investors.
Insider Buying and Selling at McKesson
In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction on Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the sale, the chief accounting officer directly owned 328 shares in the company, valued at $282,614.64. The trade was a 50.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 11,930 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the completion of the transaction, the chief executive officer directly owned 4,012 shares in the company, valued at $2,830,987.56. This trade represents a 74.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.08% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on MCK
McKesson Stock Up 0.7%
McKesson stock opened at $861.33 on Wednesday. McKesson Corporation has a 52 week low of $558.13 and a 52 week high of $867.63. The company’s 50 day moving average price is $779.78 and its two-hundred day moving average price is $731.82. The stock has a market cap of $106.31 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.46 and a beta of 0.51.
McKesson (NYSE:MCK – Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.84 by $1.02. The company had revenue of $103.15 billion during the quarter, compared to analyst estimates of $103.80 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.McKesson’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period in the prior year, the company posted $7.07 earnings per share. On average, equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.
McKesson Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Monday, December 1st will be given a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 10.21%.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- How to Invest in the FAANG Stocks
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- How to trade using analyst ratings
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- What is a Secondary Public Offering? What Investors Need to Know
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
